Women's Health

News on women's health diagnostics, including prenatal testing, STD testing, and cancer testing

The group that advises primary care clinicians found evidence that false-positive screening results could lead to surgical interventions in asymptomatic patients.

The researchers are developing a clinical assay that would use multiple biomarkers to analyze low-abundance peptides indicative of preterm risk. 

The contract includes a milestone of approval by the Chinese Food and Drug Agency within the next three years.

The planned test will be based on LifeCodexx's methylation-specific quantitative PCR technology.

The test will be developed in Global Good labs and ported onto QuantuMDx's handheld molecular platform.